Wolff-Parkinson-White Syndrome Management

Diagnosis and Prevalence

• The American Heart Association notes that the degree of pre-excitation varies based on relative conduction through the AV node versus the accessory pathway 1
• The prevalence of WPW syndrome is 0.15-0.25% in the general population, with a higher prevalence of 0.55% in first-degree relatives, suggesting a genetic component 1
• The European Society of Cardiology states that intermittent pre-excitation indicates a longer accessory pathway refractory period and lower risk 1, 2

Management Strategy

• The European Heart Journal recommends catheter ablation as the first-line definitive therapy for symptomatic WPW patients, particularly those with syncope, documented AF, or short bypass tract refractory period (<250 ms) 3, 4, 5
• The American College of Cardiology indicates that symptomatic patients with AF and WPW syndrome should undergo catheter ablation (Class I) 3, 4, 5
• The European Heart Journal advises against administering AV nodal blocking agents in WPW with pre-excited AF, as this can increase the risk of ventricular fibrillation 3, 4, 5, 7

Risk Stratification

• The American Heart Association identifies high-risk features for sudden cardiac death, including short pre-excited R-R interval <250 ms during AF, history of symptomatic tachycardia, multiple accessory pathways, Ebstein's anomaly, and familial WPW 1, 2, 3, 4, 5, 8
• The European Society of Cardiology reports a sudden cardiac death incidence of 0.15-0.39% over 3-10 years follow-up 1, 2, 8

Acute Management

• The European Heart Journal recommends immediate electrical cardioversion for hemodynamically unstable AF with rapid ventricular response 3, 4, 5
• The American College of Cardiology suggests intravenous procainamide or ibutilide for wide QRS complex (≥120 ms) in hemodynamically stable pre-excited AF 3, 4, 5
• The European Heart Journal advises against administering digoxin, diltiazem, verapamil, or beta-blockers in WPW with pre-excited AF, as these agents can increase the risk of ventricular fibrillation 3, 4, 5, 7